Entera Bio Ltd. (ENTX)
2.84
-0.17
(-5.65%)
USD |
NASDAQ |
Sep 09, 16:00
2.84
0.00 (0.00%)
After-Hours: 17:07
Entera Bio Total Assets (Quarterly) : 19.48M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.48M |
| March 31, 2026 | 13.13M |
| December 31, 2025 | 15.99M |
| September 30, 2025 | 17.41M |
| June 30, 2025 | 19.67M |
| March 31, 2025 | 21.60M |
| December 31, 2024 | 9.39M |
| September 30, 2024 | 7.741M |
| June 30, 2024 | 10.04M |
| March 31, 2024 | 10.24M |
| December 31, 2023 | 11.76M |
| September 30, 2023 | 8.565M |
| June 30, 2023 | 10.44M |
| March 31, 2023 | 11.61M |
| December 31, 2022 | 13.13M |
| September 30, 2022 | 15.54M |
| June 30, 2022 | 19.09M |
| March 31, 2022 | 22.31M |
| December 31, 2021 | 25.99M |
| Date | Value |
|---|---|
| September 30, 2021 | 29.12M |
| June 30, 2021 | 28.94M |
| March 31, 2021 | 18.53M |
| December 31, 2020 | 9.722M |
| September 30, 2020 | 8.78M |
| June 30, 2020 | 11.46M |
| March 31, 2020 | 15.18M |
| December 31, 2019 | 16.70M |
| September 30, 2019 | 7.323M |
| June 30, 2019 | 9.051M |
| March 31, 2019 | 11.40M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 13.28M |
| September 30, 2017 | 4.22M |
| June 30, 2017 | 3.658M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioLineRx Ltd. | 33.48M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 383.16M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 18.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.21M |
| Shareholders Equity (Quarterly) | 7.266M |
| Debt to Equity Ratio | 0.0585 |
| Current Ratio | 8.981 |
| Net Debt Paydown Yield | -0.05% |